[
For members enrolled in an IBC prescription drug program, prior 
authorization and quantity limit requirements will
be applied to certain drugs. The purpose of prior authorization is to ensure 
that drugs are medically necessary and
are being used appropriately. Quantity limits are designed to allow a 
sufficient supply of medication based upon the
maximum daily dose and length of therapy approved by the U.S. Food and Drug 
Administration for a particular drug.
The most recent updates are reflected below.
Drugs requiring prior authorization
The prior authorization requirement for the following non-formulary drugs 
was effective at the time the drugs became
available in the marketplace:
Brand
	Generic drug
		Drug category
			Effective date
Actemra®  SC
	Not available
		Bone, Joint, & Muscle
			November 1, 2013
Adempas®
	Not available
		 Heart, Blood Pressure, & Cholesterol
			October 11, 2013
Breo? Ellipta?
	Not available
		Allergy, Cough & Cold, Lung Meds
			July 12, 2013
Brintellix®
	Not available
		Pain, Nervous System, & Psych
			October 11, 2013
Gilotrif?
	Not available
		Cancer & Organ Transplant Drugs
			August 23, 2013
Opsumit®
	Not available
		Heart, Blood Pressure, & Cholesterol
			October 25, 2013
			
			
			The following drugs have been added to the list of drugs requiring prior 
authorization. Members taking these drugs
			prior to the effective date are not affected.
			
Brand drug
	Generic drug
		Drug category
			Effective date
Advate® 
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Alphanate®
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Alphanine® SD
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Androgel®
	Not available
		 Diabetes, Thyroid, Steroids, & Other Miscellaneous Hormones
			April 1, 2014
Bebulin®
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Belviq®
	Not available
		Pain, Nervous System, & Psych
			April 1, 2014
BeneFIX®
	Not available 
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Feiba®
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Helixate® FS
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Hemofil® M
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Humate-P®
	 Not available
		 Diagnostics & Miscellaneous Agents
			April 1, 2014
Koate®-DVI
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Kogenate® FS
	Not available 
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Letairis®
	Not available
		Heart, Blood Pressure, & Cholesterol
			April 1, 2014
Monoclate-P®
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Mononine®
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Novoseven® RT
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Profilnine® SD
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Recombinate?
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Rixubis?
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Tracleer®
	Not available
		Heart, Blood Pressure, & Cholesterol
			April 1, 2014
Tyvaso®
	Not available
		Heart, Blood Pressure, & Cholesterol
			April 1, 2014
Valchlor?
	Not available
		Cancer & Organ Transplant Drugs
			April 1, 2014
Ventavis®
	Not available
		Heart, Blood Pressure, & Cholesterol
			April 1, 2014
Wilate®
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Xyntha®
	Not available
		Diagnostics & Miscellaneous Agents
			April 1, 2014
Zohydro? ER 
	Not available
		Pain, Nervous System, & Psych 
			When drug becomes available
			 
			Drug no longer requiring prior authorization
			
			Effective February 1, 2014, prior authorization was removed for the following 
drug:
			
Brand drug
	Generic drug
		Drug category
Rozerem®
	ramelteon
		Pain, Nervous System, & Psych
		
		Drugs with quantity limits
		
		Effective April 1, 2014, quantity limits will be added for the following drugs:
		
Brand drug
	Generic drug
		Quantity limit
Actemra® SC
	Not available
		3.6 ml per 30 days
Depo-Provera®
104 mg, 150 mg
	medroxyprogesterone
acetate
		1 vial/syringe per 90 days (applies to both brand and generic)
Esomeprazole
Strontium
	Not available
		30 caps per 30 days
Nuvaring®
	Not available
		1 ring per 30 days
Ortho Evra® Patch
	Not available
		3 patches per 30 days
Zohydro? ER
	Not available
		6 per 30 days (when drug becomes available)
		
]